Tofacitinib
- Part D specialty tier in 56% of formularies (2026Q3)
- Xeljanz
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Tofacitinib: storage and handling
- Freezing
- Not addressed
- Room temperature
- at or below 25°C (77°F)
Label statement
Storage and Handling for XELJANZ Tablets/XELJANZ XR Store XELJANZ tablets and XELJANZ XR at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature].
- Room temperature
- at or below 30°C (86°F)
Label statement
Storage and Handling for XELJANZ Oral Solution Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F). [See USP Controlled Room Temperature].
- Room temperature
- at or below 25°C (77°F)
Label statement
Store XELJANZ oral solution at room temperature between 68°F to 77°F (20°C to 25°C). .
- Back into the refrigerator
- Not addressed
- Light
- Protect from light
Label statement
Store in the original bottle and carton to protect from light.
- Shaking
- Not addressed
All storage statements on the label (7)
- Storage and Handling for XELJANZ Tablets/XELJANZ XR Store XELJANZ tablets and XELJANZ XR at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature].
- Storage and Handling for XELJANZ Oral Solution Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F). [See USP Controlled Room Temperature].
- Store in the original bottle and carton to protect from light.
- Discard unused oral solution after 60 days.
- How should I store XELJANZ? .
- Store XELJANZ oral solution at room temperature between 68°F to 77°F (20°C to 25°C). .
- Always store XELJANZ oral solution in the original bottle and carton to protect from light.
FDA label version 54, effective July 12, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.